These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26779679)

  • 1. Solution-phase synthesis and biological evaluation of triostin A and its analogues.
    Hattori K; Koike K; Okuda K; Hirayama T; Ebihara M; Takenaka M; Nagasawa H
    Org Biomol Chem; 2016 Feb; 14(6):2090-111. PubMed ID: 26779679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
    Xia Y; Jin Y; Kaur N; Choi Y; Lee K
    Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors.
    Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J
    Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hypoxia-targeting Pt(iv) prodrugs.
    Xu Z; Zhao J; Gou S; Xu G
    Chem Commun (Camb); 2017 Mar; 53(26):3749-3752. PubMed ID: 28303266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
    Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
    Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
    Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
    Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
    Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
    Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Conformation-Activity Study of Unnatural Bridged Bicyclic Depsipeptides as Highly Potent Hypoxia Inducible Factor-1 Inhibitors and Antitumor Agents.
    Koike K; Nagano M; Ebihara M; Hirayama T; Tsuji M; Suga H; Nagasawa H
    J Med Chem; 2020 Apr; 63(8):4022-4046. PubMed ID: 32202785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthogonal chemistry for the synthesis of thiocoraline-triostin hybrids. Exploring their structure-activity relationship.
    Tulla-Puche J; Auriemma S; Falciani C; Albericio F
    J Med Chem; 2013 Jul; 56(13):5587-600. PubMed ID: 23746132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
    Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α.
    Shimizu T; Takahashi N; Huber VJ; Asawa Y; Ueda H; Yoshimori A; Muramatsu Y; Seimiya H; Kouji H; Nakamura H; Oguri H
    Bioorg Med Chem; 2021 Jan; 30():115949. PubMed ID: 33360196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
    Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
    Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors.
    Li G; Dong H; Ma Y; Shao K; Li Y; Wu X; Wang S; Shao Y; Zhao W
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2327-2331. PubMed ID: 31281016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of kresoxim-methyl analogues as novel inhibitors of hypoxia-inducible factor (HIF)-1 accumulation in cancer cells.
    Lee S; Kwon OS; Lee CS; Won M; Ban HS; Ra CS
    Bioorg Med Chem Lett; 2017 Jul; 27(13):3026-3029. PubMed ID: 28526370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
    Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H
    Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
    Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
    Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors.
    Yang Y; Zhao L; Xu B; Yang L; Zhang J; Zhang H; Zhou J
    Bioorg Chem; 2016 Oct; 68():236-44. PubMed ID: 27580186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.